{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:06:36Z","timestamp":1782518796592,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2413 'SynAge'"],"award-info":[{"award-number":["RTG 2413 'SynAge'"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2413 'SynAge'"],"award-info":[{"award-number":["RTG 2413 'SynAge'"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2413 'SynAge'"],"award-info":[{"award-number":["RTG 2413 'SynAge'"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union program EFRE","award":["ZS\/2018\/11\/95581"],"award-info":[{"award-number":["ZS\/2018\/11\/95581"]}]},{"name":"European Union program EFRE","award":["ZS\/2018\/11\/95581"],"award-info":[{"award-number":["ZS\/2018\/11\/95581"]}]},{"name":"European Union program EFRE","award":["ZS\/2018\/11\/95581"],"award-info":[{"award-number":["ZS\/2018\/11\/95581"]}]},{"name":"Alzheimer Forschungs Initiative  e.V","award":["DE-20057p"],"award-info":[{"award-number":["DE-20057p"]}]},{"name":"Leibniz-Institut f\u00fcr Neurobiologie (LIN)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Two connected histopathological hallmarks of Alzheimer\u2019s disease (AD) are chronic neuroinflammation and synaptic dysfunction. The accumulation of the most prevalent posttranslationally modified form of A\u03b21\u201342, pyroglutamylated amyloid-\u03b2 (A\u03b23(pE)-42) in astrocytes is directly linked to glial activation and the release of proinflammatory cytokines that in turn contribute to early synaptic dysfunction in AD. At present, the mechanisms of A\u03b23(pE)-42 uptake to astrocytes are unknown and pharmacological interventions that interfere with this process are not available. Here we developed a simple screening assay to identify substances from a plant extract library that prevent astroglial A\u03b23(pE)-42 uptake. We first show that this approach yields valid and reproducible results. Second, we show endocytosis of A\u03b23(pE)-42 oligomers by astrocytes and that quercetin, a plant flavonol, is effective to specifically block astrocytic buildup of oligomeric A\u03b23(pE)-42. Importantly, quercetin does not induce a general impairment of endocytosis. However, it efficiently protects against early synaptic dysfunction following exogenous A\u03b23(pE)-42 application.<\/jats:p>","DOI":"10.1007\/s12035-024-04509-6","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:33:48Z","timestamp":1727220828000},"page":"3730-3745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Screen of Plant-Based Natural Products Revealed That Quercetin Prevents Pyroglutamylated Amyloid-\u03b2 (A\u03b23(pE)-42) Uptake in Astrocytes As Well As Resulting Astrogliosis and Synaptic Dysfunction"],"prefix":"10.1007","volume":"62","author":[{"given":"Helene","family":"Arndt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bachurski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PingAn","family":"Yuanxiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger A.","family":"Wessjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-6950","authenticated-orcid":false,"given":"Michael R.","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8298-176X","authenticated-orcid":false,"given":"Katarzyna M.","family":"Grochowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"issue":"6","key":"4509_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25\u00a0years. EMBO Mol Med 8(6):595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"4509_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2020.12.021","volume":"101","author":"JD Mondrag\u00f3n","year":"2021","unstructured":"Mondrag\u00f3n JD, Maurits NM, De Deyn PP (2021) Functional connectivity differences in Alzheimer\u2019s disease and amnestic mild cognitive impairment associated with AT(N) classification and anosognosia. Neurobiol Aging 101:22\u201339. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.12.021","journal-title":"Neurobiol Aging"},{"issue":"7","key":"4509_CR3","doi-asserted-by":"publisher","first-page":"e3001694","DOI":"10.1371\/journal.pbio.3001694","volume":"20","author":"C Haass","year":"2022","unstructured":"Haass C, Selkoe D (2022) If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? PLoS Biol 20(7):e3001694. https:\/\/doi.org\/10.1371\/journal.pbio.3001694","journal-title":"PLoS Biol"},{"issue":"5594","key":"4509_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298(5594):789\u2013791. https:\/\/doi.org\/10.1126\/science.1074069","journal-title":"Science"},{"issue":"11","key":"4509_CR5","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/jneurosci.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27(11):2866\u20132875. https:\/\/doi.org\/10.1523\/jneurosci.4970-06.2007","journal-title":"J Neurosci"},{"issue":"4","key":"4509_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405. https:\/\/doi.org\/10.1016\/s1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"4509_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","volume":"144","author":"LM Osborn","year":"2016","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, Hol EM (2016) Astrogliosis: an integral player in the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol 144:121\u2013141. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.01.001","journal-title":"Prog Neurobiol"},{"issue":"18","key":"4509_CR8","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1111\/bph.14568","volume":"176","author":"JS Sadick","year":"2019","unstructured":"Sadick JS, Liddelow SA (2019) Don\u2019t forget astrocytes when targeting Alzheimer\u2019s disease. Br J Pharmacol 176(18):3585\u20133598. https:\/\/doi.org\/10.1111\/bph.14568","journal-title":"Br J Pharmacol"},{"issue":"6286","key":"4509_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"key":"4509_CR10","doi-asserted-by":"publisher","first-page":"899251","DOI":"10.3389\/fncel.2022.899251","volume":"16","author":"LA Hulshof","year":"2022","unstructured":"Hulshof LA, van Nuijs D, Hol EM, Middeldorp J (2022) The role of astrocytes in synapse loss in Alzheimer\u2019s disease: a systematic review. Front Cell Neurosci 16:899251. https:\/\/doi.org\/10.3389\/fncel.2022.899251","journal-title":"Front Cell Neurosci"},{"key":"4509_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2015.01.007","volume":"323","author":"JJ Rodr\u00edguez-Arellano","year":"2016","unstructured":"Rodr\u00edguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A (2016) Astrocytes in physiological aging and Alzheimer\u2019s disease. Neuroscience 323:170\u2013182. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.01.007","journal-title":"Neuroscience"},{"issue":"1","key":"4509_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura AN, Paumier A, Onur TS, Allen NJ (2023) Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci 24(1):23\u201339. https:\/\/doi.org\/10.1038\/s41583-022-00641-1","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"4509_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt258","volume":"6","author":"MP Kummer","year":"2014","unstructured":"Kummer MP, Heneka MT (2014) Truncated and modified amyloid-beta species. Alzheimers Res Ther 6(3):28. https:\/\/doi.org\/10.1186\/alzrt258","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"4509_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","volume":"127","author":"TA Bayer","year":"2014","unstructured":"Bayer TA, Wirths O (2014) Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer\u2019s disease. Acta Neuropathol 127(6):787\u2013801. https:\/\/doi.org\/10.1007\/s00401-014-1287-x","journal-title":"Acta Neuropathol"},{"issue":"7400","key":"4509_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature11060","volume":"485","author":"JM Nussbaum","year":"2012","unstructured":"Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B et al (2012) Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-\u03b2. Nature 485(7400):651\u2013655. https:\/\/doi.org\/10.1038\/nature11060","journal-title":"Nature"},{"key":"4509_CR16","doi-asserted-by":"publisher","unstructured":"Hielscher-Michael S, Griehl C, Buchholz M, Demuth HU, Arnold N, and Wessjohann LA (2016) Natural Products from microalgae with potential against Alzheimer\u2019s disease: sulfolipids sre potent glutaminyl cyclase inhibitors. Mar Drugs 14(11) https:\/\/doi.org\/10.3390\/md14110203","DOI":"10.3390\/md14110203"},{"issue":"3","key":"4509_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83(3):770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285","journal-title":"J Nat Prod"},{"key":"4509_CR18","doi-asserted-by":"publisher","unstructured":"Wirth S, Schl\u00f6\u00dfer A, Beiersdorfer A, Schweizer M, Woo MS, Friese MA, Lohr C, and Grochowska KM Astrocytic uptake of posttranslationally modified amyloid-\u03b2 leads to endolysosomal system disruption and induction of pro-inflammatory signaling. Glia n\/a(n\/a) https:\/\/doi.org\/10.1002\/glia.24539","DOI":"10.1002\/glia.24539"},{"key":"4509_CR19","doi-asserted-by":"publisher","unstructured":"Grochowska KM, Yuanxiang P, B\u00e4r J, Raman R, Brugal G, Sahu G, Schweizer M, Bikbaev A et al (2017) Posttranslational modification impact on the mechanism by which amyloid-\u03b2 induces synaptic dysfunction. EMBO Rep 18(6):962\u2013981. https:\/\/doi.org\/10.15252\/embr.201643519","DOI":"10.15252\/embr.201643519"},{"issue":"36","key":"4509_CR20","doi-asserted-by":"publisher","first-page":"12790","DOI":"10.1523\/JNEUROSCI.1794-11.2011","volume":"31","author":"A Alexandru","year":"2011","unstructured":"Alexandru A, Jagla W, Graubner S, Becker A, B\u00e4uscher C, Kohlmann S, Sedlmeier R, Raber KA et al (2011) Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated A\u03b2 is induced by pyroglutamate-A\u03b2 formation. J Neurosci: off J Soc Neurosci 31(36):12790\u201312801. https:\/\/doi.org\/10.1523\/JNEUROSCI.1794-11.2011","journal-title":"J Neurosci: off J Soc Neurosci"},{"key":"4509_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phrs.2016.01.011","volume":"105","author":"T Krajnovi\u0107","year":"2016","unstructured":"Krajnovi\u0107 T, Kalu\u0111erovi\u0107 GN, Wessjohann LA, Mijatovi\u0107 S, Maksimovi\u0107-Ivani\u0107 D (2016) Versatile antitumor potential of isoxanthohumol: enhancement of paclitaxel activity in vivo. Pharmacol Res 105:62\u201373. https:\/\/doi.org\/10.1016\/j.phrs.2016.01.011","journal-title":"Pharmacol Res"},{"issue":"6","key":"4509_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/bph.14943","volume":"177","author":"EM Williamson","year":"2020","unstructured":"Williamson EM, Liu X, Izzo AA (2020) Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals. Br J Pharmacol 177(6):1227\u20131240. https:\/\/doi.org\/10.1111\/bph.14943","journal-title":"Br J Pharmacol"},{"key":"4509_CR23","doi-asserted-by":"publisher","first-page":"173974","DOI":"10.1016\/j.ejphar.2021.173974","volume":"898","author":"T Noori","year":"2021","unstructured":"Noori T, Dehpour AR, Sureda A, Sobarzo-Sanchez E, Shirooie S (2021) Role of natural products for the treatment of Alzheimer\u2019s disease. Eur J Pharmacol 898:173974. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173974","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"4509_CR24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4103\/1673-5374.253509","volume":"14","author":"P Deshpande","year":"2019","unstructured":"Deshpande P, Gogia N, Singh A (2019) Exploring the efficacy of natural products in alleviating Alzheimer\u2019s disease. Neural Regen Res 14(8):1321\u20131329. https:\/\/doi.org\/10.4103\/1673-5374.253509","journal-title":"Neural Regen Res"},{"key":"4509_CR25","doi-asserted-by":"publisher","unstructured":"Mattioli R, Francioso A, d\u2019Erme M, Trovato M, Mancini P, Piacentini L, Casale AM, Wessjohann L, et al (2019) Anti-inflammatory activity of a polyphenolic extract from Arabidopsis thaliana in in vitro and in vivo models of Alzheimer\u2019s disease. Int J Mol Sci 20(3) https:\/\/doi.org\/10.3390\/ijms20030708","DOI":"10.3390\/ijms20030708"},{"issue":"10","key":"4509_CR26","doi-asserted-by":"publisher","first-page":"eaat6994","DOI":"10.1126\/sciadv.aat6994","volume":"4","author":"B Michels","year":"2018","unstructured":"Michels B, Zwaka H, Bartels R, Lushchak O, Franke K, Endres T, Fendt M, Song I et al (2018) Memory enhancement by ferulic acid ester across species. Sci Adv 4(10):eaat6994. https:\/\/doi.org\/10.1126\/sciadv.aat6994","journal-title":"Sci Adv"},{"issue":"7","key":"4509_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C et al (2012) Fiji: an open-source platform for biological-image analysis. Nat methods 9(7):676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat methods"},{"key":"4509_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2016.01.008","volume":"40","author":"P Yuan Xiang","year":"2016","unstructured":"Yuan Xiang P, Janc O, Grochowska KM, Kreutz MR, Reymann KG (2016) Dopamine agonists rescue A\u03b2-induced LTP impairment by Src-family tyrosine kinases. Neurobiol Aging 40:98\u2013102. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.01.008","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"4509_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2008.10.007","volume":"206","author":"I H\u00e4ke","year":"2009","unstructured":"H\u00e4ke I, Sch\u00f6nenberger S, Neumann J, Franke K, Paulsen-Merker K, Reymann K, Ismail G, Bin Din L et al (2009) Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissue. J Neuroimmunol 206(1\u20132):91\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.10.007","journal-title":"J Neuroimmunol"},{"issue":"9","key":"4509_CR30","first-page":"701","volume":"60","author":"TT Thuy","year":"2005","unstructured":"Thuy TT, Porzel A, Franke K, Wessjohann L, Sung TV (2005) Isoquinolone and protoberberine alkaloids from Stephania rotunda. Pharmazie 60(9):701\u2013704","journal-title":"Pharmazie"},{"issue":"12","key":"4509_CR31","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1111\/pbi.13141","volume":"17","author":"P Rizzo","year":"2019","unstructured":"Rizzo P, Altschmied L, Stark P, Rutten T, G\u00fcndel A, Scharfenberg S, Franke K, B\u00e4umlein H et al (2019) Discovery of key regulators of dark gland development and hypericin biosynthesis in St. John\u2019s Wort (Hypericum perforatum). Plant Biotechnol J 17(12):2299\u20132312. https:\/\/doi.org\/10.1111\/pbi.13141","journal-title":"Plant Biotechnol J"},{"issue":"2","key":"4509_CR32","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms24021328","volume":"24","author":"I Ware","year":"2023","unstructured":"Ware I, Franke K, Dube M, Ali El Enshasy H, Wessjohann LA (2023) Characterization and bioactive potential of secondary metabolites isolated from Piper sarmentosum Roxb. Int J Mol Sci 24(2):1328","journal-title":"Int J Mol Sci"},{"key":"4509_CR33","doi-asserted-by":"publisher","unstructured":"Deepika and Maurya PK (2022) Health benefits of quercetin in age-related diseases. Molecules 27(8) https:\/\/doi.org\/10.3390\/molecules27082498","DOI":"10.3390\/molecules27082498"},{"key":"4509_CR34","doi-asserted-by":"publisher","first-page":"104911","DOI":"10.1016\/j.jff.2021.104911","volume":"88","author":"L-M Geng","year":"2022","unstructured":"Geng L-M, Jiang J-G (2022) The neuroprotective effects of formononetin: signaling pathways and molecular targets. J Funct Foods 88:104911. https:\/\/doi.org\/10.1016\/j.jff.2021.104911","journal-title":"J Funct Foods"},{"issue":"1","key":"4509_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41420-023-01592-x","volume":"9","author":"A Schiavi","year":"2023","unstructured":"Schiavi A, Cirotti C, Gerber L-S, Di Lauro G, Maglioni S, Shibao PYT, Montresor S, Kirstein J et al (2023) Abl depletion via autophagy mediates the beneficial effects of quercetin against Alzheimer pathology across species. Cell Death Discovery 9(1):376. https:\/\/doi.org\/10.1038\/s41420-023-01592-x","journal-title":"Cell Death Discovery"},{"issue":"19","key":"4509_CR36","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1080\/10408398.2019.1683810","volume":"60","author":"HG Ulusoy","year":"2020","unstructured":"Ulusoy HG, Sanlier N (2020) A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities. Crit Rev Food Sci Nutr 60(19):3290\u20133303. https:\/\/doi.org\/10.1080\/10408398.2019.1683810","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4509_CR37","doi-asserted-by":"publisher","unstructured":"Grochowska KM, Gomes GM, Raman R, Kaushik R, Sosulina L, Kaneko H, Oelschlegel AM, Yuanxiang P, et al (2023) Jacob-induced transcriptional inactivation of CREB promotes A\u03b2-induced synapse loss in Alzheimer\u2019s disease. The EMBO Journal n\/a(n\/a):e112453. https:\/\/doi.org\/10.15252\/embj.2022112453","DOI":"10.15252\/embj.2022112453"},{"issue":"10","key":"4509_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11(10):682\u2013696. https:\/\/doi.org\/10.1038\/nrn2911","journal-title":"Nat Rev Neurosci"},{"key":"4509_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-022-00641-1","author":"AN Brandebura","year":"2022","unstructured":"Brandebura AN, Paumier A, Onur TS, Allen NJ (2022) Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/s41583-022-00641-1","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"4509_CR40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10(6):839\u2013850. https:\/\/doi.org\/10.1016\/j.devcel.2006.04.002","journal-title":"Dev Cell"},{"key":"4509_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-0716-1044-2_6","volume":"2233","author":"M Potokar","year":"2021","unstructured":"Potokar M, Jorga\u010devski J, Zorec R (2021) Methods for monitoring endocytosis in astrocytes. Methods Mol Biol 2233:93\u2013100. https:\/\/doi.org\/10.1007\/978-1-0716-1044-2_6","journal-title":"Methods Mol Biol"},{"issue":"12","key":"4509_CR42","doi-asserted-by":"publisher","first-page":"e14471","DOI":"10.1111\/jfbc.14471","volume":"46","author":"KS Alharbi","year":"2022","unstructured":"Alharbi KS, Afzal O, Altamimi ASA, Almalki WH, Kazmi I, Al-Abbasi FA, Alzarea SI, Makeen HA et al (2022) A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases. J Food Biochem 46(12):e14471. https:\/\/doi.org\/10.1111\/jfbc.14471","journal-title":"J Food Biochem"},{"issue":"1","key":"4509_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14283\/jpad.2021.62","volume":"9","author":"MM Gonzales","year":"2022","unstructured":"Gonzales MM, Garbarino VR, Marques Zilli E, Petersen RC, Kirkland JL, Tchkonia T, Musi N, Seshadri S et al (2022) Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): a pilot clinical trial. J Prev Alzheimers Dis 9(1):22\u201329. https:\/\/doi.org\/10.14283\/jpad.2021.62","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"4509_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, Steinh\u00e4user C, Volterra A et al (2021) Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24(3):312\u2013325. https:\/\/doi.org\/10.1038\/s41593-020-00783-4","journal-title":"Nat Neurosci"},{"issue":"1","key":"4509_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1152\/physrev.00014.2003","volume":"84","author":"MA Lynch","year":"2004","unstructured":"Lynch MA (2004) Long-term potentiation and memory. Physiol Rev 84(1):87\u2013136. https:\/\/doi.org\/10.1152\/physrev.00014.2003","journal-title":"Physiol Rev"},{"issue":"12","key":"4509_CR46","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.neurobiolaging.2010.01.011","volume":"32","author":"R R\u00f6nicke","year":"2011","unstructured":"R\u00f6nicke R, Mikhaylova M, R\u00f6nicke S, Meinhardt J, Schr\u00f6der UH, F\u00e4ndrich M, Reiser G, Kreutz MR et al (2011) Early neuronal dysfunction by amyloid \u03b2 oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging 32(12):2219\u20132228. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.01.011","journal-title":"Neurobiol Aging"},{"issue":"11","key":"4509_CR47","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95(11):6448\u20136453. https:\/\/doi.org\/10.1073\/pnas.95.11.6448","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4509_CR48","doi-asserted-by":"publisher","unstructured":"Wong CO (2020) Endosomal-lysosomal processing of neurodegeneration-associated proteins in astrocytes. Int J Mol Sci 21(14) https:\/\/doi.org\/10.3390\/ijms21145149","DOI":"10.3390\/ijms21145149"},{"issue":"1","key":"4509_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-024-00740-w","volume":"19","author":"S Kim","year":"2024","unstructured":"Kim S, Chun H, Kim Y, Kim Y, Park U, Chu J, Bhalla M, Choi S-H et al (2024) Astrocytic autophagy plasticity modulates A\u03b2 clearance and cognitive function in Alzheimer\u2019s disease. Mol Neurodegener 19(1):55. https:\/\/doi.org\/10.1186\/s13024-024-00740-w","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4509_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41467-021-27702-w","volume":"13","author":"Z Jiwaji","year":"2022","unstructured":"Jiwaji Z, Tiwari SS, Avil\u00e9s-Reyes RX, Hooley M, Hampton D, Torvell M, Johnson DA, McQueen J et al (2022) Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and A\u00df pathology. Nat Commun 13(1):135. https:\/\/doi.org\/10.1038\/s41467-021-27702-w","journal-title":"Nat Commun"},{"issue":"28","key":"4509_CR51","doi-asserted-by":"publisher","first-page":"E6640","DOI":"10.1073\/pnas.1801612115","volume":"115","author":"H Prasad","year":"2018","unstructured":"Prasad H, Rao R (2018) Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. Proc Natl Acad Sci 115(28):E6640\u2013E6649. https:\/\/doi.org\/10.1073\/pnas.1801612115","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4509_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s004010000199","volume":"100","author":"J Wegiel","year":"2000","unstructured":"Wegiel J, Wang KC, Tarnawski M, Lach B (2000) Microglial cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation. Acta Neuropathol 100(4):356\u2013364. https:\/\/doi.org\/10.1007\/s004010000199","journal-title":"Acta Neuropathol"},{"issue":"45","key":"4509_CR53","doi-asserted-by":"publisher","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","volume":"286","author":"S Jawhar","year":"2011","unstructured":"Jawhar S, Wirths O, Bayer TA (2011) Pyroglutamate amyloid-\u03b2 (A\u03b2): a hatchet man in Alzheimer disease*. J Biol Chem 286(45):38825\u201338832. https:\/\/doi.org\/10.1074\/jbc.R111.288308","journal-title":"J Biol Chem"},{"issue":"2","key":"4509_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC, Iwatsubo T, Mann DMA, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct \u03b2-amyloid peptide species, A\u03b2N3(pE), in senile plaques. Neuron 14(2):457\u2013466. https:\/\/doi.org\/10.1016\/0896-6273(95)90301-1","journal-title":"Neuron"},{"issue":"5","key":"4509_CR55","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","volume":"121","author":"D Schlenzig","year":"2012","unstructured":"Schlenzig D, R\u00f6nicke R, Cynis H, Ludwig H-H, Scheel E, Reymann K, Saido T, Hause G et al (2012) N-Terminal pyroglutamate formation of A\u03b238 and A\u03b240 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation. J Neurochem 121(5):774\u2013784. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07707.x","journal-title":"J Neurochem"},{"issue":"16","key":"4509_CR56","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1002\/anie.201511099","volume":"55","author":"M Wulff","year":"2016","unstructured":"Wulff M, Baumann M, Th\u00fcmmler A, Yadav JK, Heinrich L, Kn\u00fcpfer U, Schlenzig D, Schierhorn A et al (2016) Enhanced fibril fragmentation of N-terminally truncated and pyroglutamyl-modified A\u03b2 peptides. Angew Chem Int Ed 55(16):5081\u20135084. https:\/\/doi.org\/10.1002\/anie.201511099","journal-title":"Angew Chem Int Ed"},{"issue":"12","key":"4509_CR57","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","volume":"18","author":"SR Bonam","year":"2019","unstructured":"Bonam SR, Wang F, Muller S (2019) Lysosomes as a therapeutic target. Nat Rev Drug Discovery 18(12):923\u2013948. https:\/\/doi.org\/10.1038\/s41573-019-0036-1","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"4509_CR58","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11481-021-09990-7","volume":"16","author":"KL Lakpa","year":"2021","unstructured":"Lakpa KL, Khan N, Afghah Z, Chen X, Geiger JD (2021) Lysosomal stress response (LSR): physiological importance and pathological relevance. J Neuroimmune Pharmacol 16(2):219\u2013237. https:\/\/doi.org\/10.1007\/s11481-021-09990-7","journal-title":"J Neuroimmune Pharmacol"},{"key":"4509_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnana.2014.00083","volume":"8","author":"M Bourdenx","year":"2014","unstructured":"Bourdenx M, Bezard E, Dehay B (2014) Lysosomes and \u03b1-synuclein form a dangerous duet leading to neuronal cell death. Front Neuroanat 8:83. https:\/\/doi.org\/10.3389\/fnana.2014.00083","journal-title":"Front Neuroanat"},{"key":"4509_CR60","doi-asserted-by":"publisher","first-page":"e51031","DOI":"10.7554\/eLife.51031","volume":"8","author":"KF Yambire","year":"2019","unstructured":"Yambire KF, Rostosky C, Watanabe T, Pacheu-Grau D, Torres-Odio S, Sanchez-Guerrero A, Senderovich O, Meyron-Holtz EG et al (2019) Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo. eLife 8:e51031. https:\/\/doi.org\/10.7554\/eLife.51031","journal-title":"eLife"},{"issue":"2","key":"4509_CR61","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.virol.2011.01.019","volume":"412","author":"AU Barlan","year":"2011","unstructured":"Barlan AU, Danthi P, Wiethoff CM (2011) Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology 412(2):306\u2013314. https:\/\/doi.org\/10.1016\/j.virol.2011.01.019","journal-title":"Virology"},{"key":"4509_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12974-016-0477-y","volume":"13","author":"J Couturier","year":"2016","unstructured":"Couturier J, Stancu IC, Schakman O, Pierrot N, Huaux F, Kienlen-Campard P, Dewachter I, Octave JN (2016) Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease. J Neuroinflammation 13:20. https:\/\/doi.org\/10.1186\/s12974-016-0477-y","journal-title":"J Neuroinflammation"},{"issue":"9","key":"4509_CR63","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","volume":"41","author":"F Giovannoni","year":"2020","unstructured":"Giovannoni F, Quintana FJ (2020) The role of astrocytes in CNS inflammation. Trends Immunol 41(9):805\u2013819. https:\/\/doi.org\/10.1016\/j.it.2020.07.007","journal-title":"Trends Immunol"},{"key":"4509_CR64","volume-title":"Herbal medicine: a guide for health care professionals","author":"JE Barnes","year":"2002","unstructured":"Barnes JE, Anderson LA, Phillipson JD (2002) Herbal medicine: a guide for health care professionals, 2nd edn. Pharmaceutical Press, UK","edition":"2"},{"key":"4509_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fnagi.2018.00411","volume":"10","author":"R Kaushik","year":"2018","unstructured":"Kaushik R, Morkovin E, Schneeberg J, Confettura AD, Kreutz MR, Senkov O, Dityatev A (2018) Traditional Japanese herbal medicine Yokukansan targets distinct but overlapping mechanisms in aged mice and in the 5xFAD mouse model of Alzheimer\u2019s disease. Front Aging Neurosci 10:411. https:\/\/doi.org\/10.3389\/fnagi.2018.00411","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"4509_CR66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.biotechadv.2016.12.005","volume":"35","author":"A Dey","year":"2017","unstructured":"Dey A, Bhattacharya R, Mukherjee A, Pandey DK (2017) Natural products against Alzheimer\u2019s disease: pharmaco-therapeutics and biotechnological interventions. Biotechnol Adv 35(2):178\u2013216. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.12.005","journal-title":"Biotechnol Adv"},{"issue":"19","key":"4509_CR67","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.2174\/0929867322666150520095509","volume":"22","author":"TS Cheung","year":"2015","unstructured":"Cheung TS, Song TH, Ng TB, Wu FH, Lao LX, Tang SC, Ho JC, Zhang KY et al (2015) Therapeutic effects of herbal chemicals in traditional Chinese medicine on Alzheimer\u2019s disease. Curr Med Chem 22(19):2392\u20132403. https:\/\/doi.org\/10.2174\/0929867322666150520095509","journal-title":"Curr Med Chem"},{"key":"4509_CR68","unstructured":"Michels B, Gerber B, Wessjohann L, Franke K, Sigrist S, Bhukel A, Lushchak O, Zwaka H, Bartels R, Dityatev A, Song I, Fendt M, Le\u00dfmann V, Endres T, and K\u00e4hne T (2019) Verbindung zur Anwendung bei der Steigerung von mentaler Leistungsf\u00e4higkeit"},{"issue":"1","key":"4509_CR69","doi-asserted-by":"publisher","first-page":"1700447","DOI":"10.1002\/mnfr.201700447","volume":"62","author":"S Andres","year":"2018","unstructured":"Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Sch\u00e4fer B, Hirsch-Ernst KI, Lampen A (2018) Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res 62(1):1700447. https:\/\/doi.org\/10.1002\/mnfr.201700447","journal-title":"Mol Nutr Food Res"},{"key":"4509_CR70","doi-asserted-by":"publisher","first-page":"665031","DOI":"10.3389\/fphar.2021.665031","volume":"12","author":"MS Islam","year":"2021","unstructured":"Islam MS, Quispe C, Hossain R, Islam MT, Al-Harrasi A, Al-Rawahi A, Martorell M, Mamurova A et al (2021) Neuropharmacological effects of quercetin: a literature-based review. Front Pharmacol 12:665031. https:\/\/doi.org\/10.3389\/fphar.2021.665031","journal-title":"Front Pharmacol"},{"key":"4509_CR71","doi-asserted-by":"publisher","unstructured":"Riche K and Lenard NR (2022) Quercetin\u2019s effects on glutamate cytotoxicity. Molecules 27(21) https:\/\/doi.org\/10.3390\/molecules27217620","DOI":"10.3390\/molecules27217620"},{"key":"4509_CR72","doi-asserted-by":"publisher","unstructured":"Holland TM, Agarwal P, Wang Y, Dhana K, Leurgans SE, Shea K, Booth SL, Rajan K, et al (2022) Association of dietary intake of flavonols with changes in global cognition and several cognitive abilities. Neurology:https:\/\/doi.org\/10.1212\/WNL.0000000000201541","DOI":"10.1212\/WNL.0000000000201541"},{"issue":"3","key":"4509_CR73","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/1541-4337.12342","volume":"17","author":"AF Almeida","year":"2018","unstructured":"Almeida AF, Borge GIA, Piskula M, Tudose A, Tudoreanu L, Valentov\u00e1 K, Williamson G, Santos CN (2018) Bioavailability of quercetin in humans with a focus on interindividual variation. Compr Rev Food Sci Food Saf 17(3):714\u2013731. https:\/\/doi.org\/10.1111\/1541-4337.12342","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"4","key":"4509_CR74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1017\/s0007114521003627","volume":"128","author":"MH Baky","year":"2022","unstructured":"Baky MH, Elshahed M, Wessjohann L, Farag MA (2022) Interactions between dietary flavonoids and the gut microbiome: a comprehensive review. Br J Nutr 128(4):577\u2013591. https:\/\/doi.org\/10.1017\/s0007114521003627","journal-title":"Br J Nutr"},{"issue":"1","key":"4509_CR75","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/10717544.2021.1927244","volume":"28","author":"H Li","year":"2021","unstructured":"Li H, Li M, Fu J, Ao H, Wang W, Wang X (2021) Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Drug Delivery 28(1):1226\u20131236. https:\/\/doi.org\/10.1080\/10717544.2021.1927244","journal-title":"Drug Delivery"},{"issue":"8","key":"4509_CR76","first-page":"4683","volume":"11","author":"Z Jin","year":"2019","unstructured":"Jin Z, Ke J, Guo P, Wang Y, Wu H (2019) Quercetin improves blood-brain barrier dysfunction in rats with cerebral ischemia reperfusion via Wnt signaling pathway. Am J Transl Res 11(8):4683\u20134695","journal-title":"Am J Transl Res"},{"issue":"4","key":"4509_CR77","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1517\/14740330903026944","volume":"8","author":"B Ossola","year":"2009","unstructured":"Ossola B, K\u00e4\u00e4ri\u00e4inen TM, M\u00e4nnist\u00f6 PT (2009) The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 8(4):397\u2013409. https:\/\/doi.org\/10.1517\/14740330903026944","journal-title":"Expert Opin Drug Saf"},{"issue":"37","key":"4509_CR78","doi-asserted-by":"publisher","first-page":"34783","DOI":"10.1074\/jbc.M305063200","volume":"278","author":"JP Spencer","year":"2003","unstructured":"Spencer JP, Rice-Evans C, Williams RJ (2003) Modulation of pro-survival Akt\/protein kinase B and ERK1\/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278(37):34783\u201334793. https:\/\/doi.org\/10.1074\/jbc.M305063200","journal-title":"J Biol Chem"},{"key":"4509_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neurobiolaging.2016.12.024","volume":"52","author":"S Baral","year":"2017","unstructured":"Baral S, Pariyar R, Kim J, Lee H-S, Seo J (2017) Quercetin-3-O-glucuronide promotes the proliferation and migration of neural stem cells. Neurobiol Aging 52:39\u201352. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.12.024","journal-title":"Neurobiol Aging"},{"issue":"2","key":"4509_CR80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.abb.2008.07.014","volume":"478","author":"K Vafeiadou","year":"2008","unstructured":"Vafeiadou K, Vauzour D, Rodriguez-Mateos A, Whiteman M, Williams RJ, Spencer JPE (2008) Glial metabolism of quercetin reduces its neurotoxic potential. Arch Biochem Biophys 478(2):195\u2013200. https:\/\/doi.org\/10.1016\/j.abb.2008.07.014","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"4509_CR81","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.freeradbiomed.2004.01.001","volume":"36","author":"RJ Williams","year":"2004","unstructured":"Williams RJ, Spencer JPE, Rice-Evans C (2004) Flavonoids: antioxidants or signalling molecules? Free Radical Biol Med 36(7):838\u2013849. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.01.001","journal-title":"Free Radical Biol Med"},{"issue":"11","key":"4509_CR82","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/s0006-2952(97)82453-7","volume":"53","author":"G Agullo","year":"1997","unstructured":"Agullo G, Gamet-Payrastre L, Manenti S, Viala C, R\u00e9m\u00e9sy C, Chap H, Payrastre B (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53(11):1649\u20131657. https:\/\/doi.org\/10.1016\/s0006-2952(97)82453-7","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"4509_CR83","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","volume":"20","author":"B Bilanges","year":"2019","unstructured":"Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 20(9):515\u2013534. https:\/\/doi.org\/10.1038\/s41580-019-0129-z","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4509_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G (2014) The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Front Aging Neurosci 6:93. https:\/\/doi.org\/10.3389\/fnagi.2014.00093","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"4509_CR85","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.bbagen.2012.12.027","volume":"1830","author":"M Zhu","year":"2013","unstructured":"Zhu M, Han S, Fink AL (2013) Oxidized quercetin inhibits \u03b1-synuclein fibrillization. Biochim Biophys Acta 1830(4):2872\u20132881. https:\/\/doi.org\/10.1016\/j.bbagen.2012.12.027","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4509_CR86","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.1471-4159.2003.01976.x","volume":"87","author":"K Ono","year":"2003","unstructured":"Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer\u2019s disease. J Neurochem 87(1):172\u2013181. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01976.x","journal-title":"J Neurochem"},{"issue":"29","key":"4509_CR87","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1021\/bi900818a","volume":"48","author":"D Schlenzig","year":"2009","unstructured":"Schlenzig D, Manhart S, Cinar Y, Kleinschmidt M, Hause G, Willbold D, Funke SA, Schilling S et al (2009) Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry 48(29):7072\u20137078. https:\/\/doi.org\/10.1021\/bi900818a","journal-title":"Biochemistry"},{"issue":"41","key":"4509_CR88","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1021\/bi0612667","volume":"45","author":"S Schilling","year":"2006","unstructured":"Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, B\u00f6hm G, Demuth H-U (2006) On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45(41):12393\u201312399. https:\/\/doi.org\/10.1021\/bi0612667","journal-title":"Biochemistry"},{"issue":"1","key":"4509_CR89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-008-9766-9","volume":"314","author":"YS Tarahovsky","year":"2008","unstructured":"Tarahovsky YS, Muzafarov EN, Kim YA (2008) Rafts making and rafts braking: how plant flavonoids may control membrane heterogeneity. Mol Cell Biochem 314(1):65\u201371. https:\/\/doi.org\/10.1007\/s11010-008-9766-9","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"4509_CR90","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"4509_CR91","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10(7):719\u2013726. https:\/\/doi.org\/10.1038\/nm1058","journal-title":"Nat Med"},{"key":"4509_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuropharm.2016.04.032","volume":"108","author":"X Zhang","year":"2016","unstructured":"Zhang X, Hu J, Zhong L, Wang N, Yang L, Liu CC, Li H, Wang X et al (2016) Quercetin stabilizes apolipoprotein E and reduces brain A\u03b2 levels in amyloid model mice. Neuropharmacology 108:179\u2013192. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.032","journal-title":"Neuropharmacology"},{"issue":"1","key":"4509_CR93","doi-asserted-by":"publisher","first-page":"22959","DOI":"10.1038\/s41598-021-02248-5","volume":"11","author":"G Zu","year":"2021","unstructured":"Zu G, Sun K, Li L, Zu X, Han T, Huang H (2021) Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus. Sci Rep 11(1):22959. https:\/\/doi.org\/10.1038\/s41598-021-02248-5","journal-title":"Sci Rep"},{"key":"4509_CR94","doi-asserted-by":"publisher","first-page":"902092","DOI":"10.3389\/fnagi.2022.902092","volume":"14","author":"C Wei","year":"2022","unstructured":"Wei C, Li S, Zhu Y, Chen W, Li C, Xu R (2022) Network pharmacology identify intersection genes of quercetin and Alzheimer\u2019s disease as potential therapeutic targets. Front Aging Neurosci 14:902092. https:\/\/doi.org\/10.3389\/fnagi.2022.902092","journal-title":"Front Aging Neurosci"},{"issue":"38","key":"4509_CR95","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1021\/acs.jpcb.2c02763","volume":"126","author":"A Alghamdi","year":"2022","unstructured":"Alghamdi A, Birch DJS, Vyshemirsky V, Rolinski OJ (2022) Impact of the flavonoid quercetin on \u03b2-amyloid aggregation revealed by intrinsic fluorescence. J Phys Chem B 126(38):7229\u20137237. https:\/\/doi.org\/10.1021\/acs.jpcb.2c02763","journal-title":"J Phys Chem B"},{"issue":"1","key":"4509_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67(1):27\u201337. https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00318.x","journal-title":"Chem Biol Drug Des"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04509-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04509-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04509-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T01:04:15Z","timestamp":1738544655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04509-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["4509"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04509-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4155455\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"23 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were carried out in accordance with the European Communities Council Directive (2010\/63\/EU) and German Animal Welfare Act.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}